AgriAmerica Logo
photo

Moderna receives project award through BARDA's rapid response partnership vehicle consortium to accelerate development of mRNA-based pandemic influenza vaccine

Tuesday, July 9, 2024 • 1 PM

Photo courtesy of Moderna

Moderna, Inc. (NASDAQ:MRNA) recently announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. 

Read More...

Cover art
© 2024 Learfield
Privacy